Evaluation of the Clinical Impact of Different Telemedicine Practices in Intensive Care Units
Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Jul 17, 2023
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is evaluating the use of telemedicine in intensive care units (ICUs) to see if it can help patients recover faster and reduce their time in the hospital. The study focuses on three main telemedicine practices: daily check-ins with a specialized doctor, a team of healthcare professionals (including nurses, physical therapists, and pharmacists) providing support, and management strategies aimed at improving the quality and safety of patient care. The goal is to determine if these practices can lower the number of days patients spend in the ICU while also looking at patient outcomes like survival rates and the need for mechanical ventilation.
To be eligible for this study, patients must be adults aged 18 and older and admitted to specific public or nonprofit hospitals with well-staffed ICUs. However, patients who are in certain specialized units or have been part of a previous related study will not be included. If you or a loved one is in the ICU and meets the criteria, participating in this trial could contribute to important findings on how telemedicine can improve care for critically ill patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for Intensive care units:
- • Intensive care units from public or philanthropic hospitals.
- • Intensive care units with physician and nurses available 24 hours a day and physiotherapist available at least ≥ 18 hours a day.
- Exclusion Criteria for Intensive care units:
- • Intensive care units with structured multidisciplinary round more than three times a week conducted by an intensive care physician (certified), documented in the medical record, with a fixed duration (\>5 min / patient), using some supporting tool (checklist or standard form), goal oriented, based on established protocols, including all the patients admitted to the ICU.
- • Intensive care units already doing audit and feedback with specific planning.
- • Dedicated coronary care units/cardiac intensive care units or other specialized units (cardiac surgery, neurological, burned patients).
- • Step-down units or semi-intensive cardiac care unit.
- • Intensive care units without availability of substitute renal therapy.
- • ICU coordinator specialist in intensive care medicine and management training (MBA in Health Management or equivalent).
- Inclusion Criteria for patients:
- • Adult patients (≥ 18 years old).
- Exclusion Criteria for patients:
- • Admission for other reasons than medical (e.g., judicial cause, legal reasons, safety reasons).
- • Previously included in the TELESCOPE II trial (for the primary outcome analysis).
About Hospital Israelita Albert Einstein
Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Adriano J Pereira, MD, PhD.
Study Director
Hospital Israelita Albert Einstein
Renato CF Chaves, MD, MBA.
Principal Investigator
Hospital Israelita Albert Einstein
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported